All posts by: Michael Zand

About Michael Zand

Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders – Memorial Sloan Kettering Cancer Center (blog)

Continue reading

2017-04-10 NEWS

Memorial Sloan Kettering Cancer Center (blog)

Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders
Memorial Sloan Kettering Cancer Center (blog)
Some patients who receive immunotherapy drugs called checkpoint inhibitors experience significant benefit in terms of tumor shrinkage and longer survival — but many do not. A new study suggests that measuring changes in the blood could help doctors …
Do We Need Biomarkers to Predict Tumor Hyper-Progression Following Immunotherapy?AJMC.com Managed Markets Network
Long term benefits of immunotherapy emerging for some patients, though key questions remainCancer Research UK
Matching tumor size to strength of immune response allows melanoma drug tailoringEurekAlert (press release)

all 4 news articles »

Continue reading

2017-04-10 NEWS

The media, synthetic biology and CRISPR – fears vs. reality
BioNews
A recent Wall Street Journal article, ‘DIY Gene Editing: Fast, Cheap – and Worrisome’, describes the Saturday afternoon of teenager, Kian Sadeghi, as he learns to use CRISPR/Cas9 at the Genspace Community Lab in Brooklyn, New York. Like many news …

Continue reading

2017-04-10 NEWS

Quartz

A new sci-fi thriller about CRISPR makes gene editing terrifyingly easy to understand
Quartz
The webbed world we live in now would have seemed like science fiction not long ago. Thriller writer Daniel Suarez believes that coming changes will be much more dramatic. He predicts that by 2045 bespoke babies—plus pets, plants, bacteria, and …

Continue reading

2017-04-10 NEWS

STAT

Mighty morphed brain cells cure Parkinson’s in mice, but human trials still far off
STAT
Instead, several labs have therefore used stem cells to produce dopamine neurons in dishes. Transplanted 4 into the brains of lab rats with Parkinson’s, the neurons reduced rigidity, tremor, and other symptoms. Human studies are expected to begin in
Cell Therapy 2.0: Reprogramming the Brain’s Own Cells for Parkinson’s TreatmentScientific American
Brain cells reprogrammed to make dopamine, with goal of Parkinson’s therapyThe San Diego Union-Tribune
Brain cell transplants could help treat Parkinson’s diseaseMedical Xpress
The Scientist
all 31 news articles »